Manufacture

The UK’s CGT Catapult has played a significant role in building the strong advanced therapy ecosystem in the UK, the largest outside the USA.

With many cell and gene therapies skipping phase III trials entirely, academics must get to grips with GMP early.

Cell and gene therapies have earned a high profile in recent years, but the field’s rate of growth has led to a gold rush on talent.

What if research hospitals could fully develop and process cell and gene therapies themselves?

Miguel Forte argues it’s time to fine tune the way we target solid tumors...

The gene therapy sector is booming, but can the industry address all the teething problems?

How an understanding of the regulatory framework is essential for the future generations of cell and gene therapy professionals.

Cell and gene therapies require the very highest levels of quality, so an effective fill-finish solution is essential to manufacturing operations.

Hovione’s New Jersey-based site has provided process development and small volume API manufacturing since 2002.

The reported benefits of continuous manufacturing for small molecules over batch manufacturing include accelerated product and process development.